🇪🇺 Imiquimod 5% cream with prior curettage in European Union

EMA authorised Imiquimod 5% cream with prior curettage on 18 September 1998

Marketing authorisation

EMA — authorised 18 September 1998

  • Application: EMEA/H/C/000179
  • Marketing authorisation holder: Viatris Healthcare Limited
  • Local brand name: Aldara
  • Indication: Imiquimod cream is indicated for the topical treatment of : External genital and perianal warts (condylomata acuminata) in adults. Small superficial basal cell carcinomas (sBCCs) in adults. Clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses (AKs) on the face or scalp in immunocompetent adult patients when size or number of lesions limit the efficacy and/or acceptability of cryotherapy and other topical treatment options are contraindicated or less appropriate.
  • Status: approved

Read official source →

Frequently asked questions

Is Imiquimod 5% cream with prior curettage approved in European Union?

Yes. EMA authorised it on 18 September 1998.

Who is the marketing authorisation holder for Imiquimod 5% cream with prior curettage in European Union?

Viatris Healthcare Limited holds the EU marketing authorisation.